IP Library Assignment 057861/0905
Patent Assignment
Reel/Frame 057861/0905

Security Interest

Recorded: 2021-10-20 Pages: 9
Assignor
KINDRED BIOSCIENCES, INC.
Executed: 2021-10-18
Assignee
GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
30 HUDSON STREET, 36TH FLOOR, JERSEY CITY, NEW JERSEY, 07302
Covered Properties (47)
Compositions and Methods for Treatment and Prevention of Pyrexia in Horses
Application: 16/869,018 →
Publication: US 2020/0330436
Methods of Using Metamizole for Treatment of Pyrexia in Equines
Application: 16/438,130 →
Publication: US 2019/0374509
Methods for Treatment and Prevention of Pyrexia in Horses
Application: 62/127,401 →
Methods of using Metamizole for Treatment of Pyrexia in Equines
Application: 62/818,221 →
Methods of Using Metamizole for Treatment of Pyrexia in Equines
Application: 62/683,882 →
Anti-IL31 Antibodies for Veterinary Use
Application: 62/463,543 →
Anti-IL31 Antibodies for Veterinary Use
Application: 17/039,495 →
Publication: US 2021/0163587
IL4/IL13 Receptor Molecule for Veterinary Use
Application: 17/287,756 →
Publication: US 2021/0395340
Feline Erythropoietin and Its Derivatives for Veterinary Use
Application: 62/516,092 →
Erythropoietin and Its Derivatives for Veterinary Use
Application: 62/516,642 →
Erythropoietin and Analogs for Veterinary Use
Application: 62/559,104 →
Erythropoietin and Analogs for Veterinary Use
Application: 16/617,380 →
Publication: US 2021/0032305
Erythropoietin Analogs for Veterinary Use
Application: 62/778,849 →
Erythropoietin Analogs for Veterinary Use
Application: 62/779,332 →
Erythropoietin Analogs for Veterinary Use
Application: 62/785,691 →
IgG Fc Variants for Veterinary Use
Application: 16/638,402 →
Publication: US 2020/0362034
Igg Fc Variants for Veterinary Use
Application: 62/545,858 →
Variant Asparaginase Polypeptides for Medical Use
Application: 62/660,189 →
Variant Asparaginase Polypeptides for Medical Use
Application: 17/048,355 →
Publication: US 2021/0062176
Anti-IL4 Receptor Antibodies for Veterinary Use
Application: 17/274,746 →
Publication: US 2022/0049002
Anti-IL4 Receptor Antibodies for Veterinary Use
Application: 62/731,633 →
IGG FC Variants for Veterinary Use
Application: 62/785,680 →
Anti-IL4 Receptor Antibodies for Veterinary Use
Application: 62/991,568 →
Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use
Application: 17/284,875 →
Publication: US 2021/0388053
IL4/IL13 Receptor Molecule for Veterinary Use
Application: 62/488,509 →
IL4/IL13 Receptor Molecule for Veterinary Use
Application: 62/750,782 →
Il4/IL13 Receptor Molecule for Veterinary Use
Application: 63/014,090 →
IL4/IL13 Receptor Molecule for Veterinary Use
Application: 63/014,573 →
IL17A Antibodies and Antagonists for Veterinary Use
Application: 62/521,514 →
IL4/IL13 Receptor Molecule for Veterinary Use
Application: 16/605,356 →
Publication: US 2020/0048325
IL17A Antibodies and Antagonists for Veterinary Use
Application: 16/621,012 →
Publication: US 2020/0199216
Anti-IL31 Antibodies for Veterinary Use
Application: 63/014,033 →
Anti-IL31 Antibodies for Veterinary Use
Application: 63/014,549 →
TNF Alpha Antibodies for Veterinary Use
Application: 63/127,994 →
TNF Alpha Antibodies for Veterinary Use
Application: 63/128,804 →
Methods of Treating a Companion Animal Species Comprising Administering Anti-IL31 Antibodies
Application: 16/488,045 →
Publication: US 2020/0062840
Anti-IL31 Antibodies for Veterinary Use
Application: 62/893,799 →
Anti-IL31 Antibodies for Veterinary Use
Application: 62/894,526 →
NGF Antagonists for Medical Use
Application: 62/821,438 →
Anti-Parvovirus Antibodies for Veterinary Use
Application: 62/880,650 →
Parvovirus Antibodies for Veterinary Use
Application: 62/968,970 →
Parvovirus Antibodies for Veterinary Use
Application: 63/030,123 →
Equine Esomeprazole Formulations and Methods of Use
Application: 62/874,702 →
Equine Esomeprazole Formulations and Methods of Use
Application: 63/038,549 →
Compositions and Methods for Treatment and Prevention of Pyrexia in Horses
Application: 15/554,568 →
Publication: US 2018/0071256
Anti-IL31 Antibodies for Veterinary Use
Application: 15/467,464 →
Publication: US 2018/0244766
Anti-IL31 Antibodies for Veterinary Use
Application: 15/844,142 →
Publication: US 2018/0244767
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 29, 2015
From: SUNDMAN, EMILY
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 035525/0840 →
Assignment of Assignor's Interest Mar 3, 2017
From: LI, SHYR JIANN; NGUYEN, LAM; ZHAN, HANGJUN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 041887/0463 →
Assignment of Assignor's Interest Jun 19, 2017
From: ZHAN, HANGJUN; NGUYEN, LAM; LI, YONGZHONG; CHU, QINGYI
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 042750/0424 →
Assignment of Assignor's Interest Jun 27, 2017
From: LI, SHYR JIANN; NGUYEN, LAM; YANG, LAN; ZHAN, HANGJUN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 042829/0512 →
Assignment of Assignor's Interest Jul 19, 2017
From: ZHAN, HANGJUN; NGUYEN, LAM; LI, YONGZHONG; CHU, QINGYI
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 043040/0575 →
Assignment of Assignor's Interest Jul 19, 2017
From: ZHAN, HANGJUN; NGUYEN, LAM; QIAN, FAWN; LI, SHYR JIANN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 043040/0506 →
Assignment of Assignor's Interest Aug 24, 2017
From: ZHAN, HANGJUN; NGUYEN, LAM; LI, YONGZHONG; QIAN, FAWN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 043389/0626 →
Assignment of Assignor's Interest Oct 25, 2017
From: ZHAN, HANGJUN; NGUYEN, LAM; LI, YONGZHONG; CHU, QINGYI
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 043947/0284 →
Assignment of Assignor's Interest May 21, 2018
From: ZHAN, HANGJUN; NGUYEN, LAM; CHIN, RICHARD; LI, SHYR JIANN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 045857/0251 →
Assignment of Assignor's Interest Jun 21, 2018
From: SUNDMAN, EMILY; O'BANION, MELINDA POOLE
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 046158/0052 →
Assignment of Assignor's Interest Oct 16, 2018
From: LI, SHYR JIANN; NGUYEN, LAM; CHIN, RICHARD; ZHAN, HANGJUN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 047185/0292 →
Assignment of Assignor's Interest Nov 15, 2018
From: ZHAN, HANGJUN; NGUYEN, LAM; QIAN, FAWN; LI, SHYR JIANN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 047516/0259 →
Assignment of Assignor's Interest Jan 15, 2019
From: ZHAN, HANGJUN; NGUYEN, LAM; CHU, QINGYI; LI, SHYR JIANN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 048012/0300 →
Assignment of Assignor's Interest Jan 16, 2019
From: ZHAN, HANGJUN; NGUYEN, LAM; LI, YONGZHONG; QIAN, FAWN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 048025/0314 →
Assignment of Assignor's Interest Apr 3, 2019
From: SUNDMAN, EMILY; O'BANION, MELINDA POOLE
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 048778/0322 →
Assignment of Assignor's Interest May 5, 2020
From: LI, SHYR JIANN; NGUYEN, LAM; CHIN, RICHARD; ZHAN, HANGJUN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 052573/0178 →
Assignment of Assignor's Interest May 13, 2020
From: ZHAN, HANGJUN; NGUYEN, LAM; QIAN, FAWN; LI, SHYR JIANN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 052648/0143 →
Assignment of Assignor's Interest May 22, 2020
From: LI, SHYR JIANN; NGUYEN, LAM; CHU, QINGYI; QIAN, FAWN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 052734/0155 →
Assignment of Assignor's Interest Jun 25, 2020
From: SUNDMAN, EMILY; O'BANION, MELINDA POOLE
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 053036/0489 →
Assignment of Assignor's Interest Jul 9, 2020
From: LI, SHYR JIANN; NGUYEN, LAM; CHU, QINGYI; CHIN, RICHARD
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 053161/0530 →
Assignment of Assignor's Interest Jul 31, 2020
From: SUNDMAN, EMILY
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 053366/0473 →
Assignment of Assignor's Interest Sep 25, 2020
From: LI, SHYR JIANN; NGUYEN, LAM; YANG, LAN; ZHAN, HANGJUN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 053881/0049 →
Assignment of Assignor's Interest Jan 14, 2021
From: ZHAN, HANGJUN; NGUYEN, LAM; LI, YONGZHONG; QIAN, FAWN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 054916/0619 →
Assignment of Assignor's Interest Jul 9, 2021
From: LI, SHYR JIANN; NGUYEN, LAM; ZHAN, HANGJUN
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 056817/0448 →
Partial Release of Security Interest Jul 22, 2022
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: KINDRED BIOSCIENCES, INC.
Reel/Frame 060814/0350 →